Evidence supporting a link between dental amalgams and chronic illness, fatigue, depression, anxiety, and suicide

Neuroendocrinology Letters

Volumn 35, Issue 7, 2014, Pages 537-552

  Kern, Janet K ^a   Geier, David A ^a   Bjørklund, Geir ^b   King, Paul G ^a   Homme, Kristin G ^c   Haley, Boyd E ^d   Sykes, Lisa K ^a   Geier, Mark R ^a  

^a Institute of Chronic Illnesses Inc ^*  (United States)

^b Department of Research   (Norway)

^c International Academy of Oral Medicine and Toxicology   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Anxiety; Chronic fatigue syndrome; Dental amalgam; Depression; Fatigue; Fibromyalgia; Hg; Mercury; Suicide

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMALGAM; ANTIOXIDANT; COPPER; GLUTATHIONE; MERCURY; PORPHYRIN; THIOREDOXIN; ZINC; MERCURY DERIVATIVE;

ABSORPTION; ALLERGY; ANXIETY; AUTOPSY; BLOOD; BRAIN; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; DENTIST; DEPRESSION; FIBROMYALGIA; FLORA; GENETIC SUSCEPTIBILITY; HEALTH; HOMEOSTASIS; HUMAN; INTESTINE; KIDNEY; MERCURIALISM; MITOCHONDRION; MOBILE PHONE; MOOD; REVIEW; SAFETY; STAFF; SUICIDE; URINE; VAPOR; EVIDENCE BASED PRACTICE; FATIGUE;

ANXIETY; CHRONIC DISEASE; DENTAL AMALGAM; DEPRESSION; EVIDENCE-BASED PRACTICE; FATIGUE; FIBROMYALGIA; HUMANS; MERCURY COMPOUNDS; SUICIDE;

EID: 84924606680     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Abraham JE, Svare CW, Frank CW (1984). The effect of dental amalgam restorations on blood mercury levels. Journal of Dental Research 63:71-73.
2. Alhamad T, Rooney J, Nwosu A, Maccombs J, Kim YS, Shukla V (2012). Lessons learned from a fatal case of mercury intoxication. International Urology and Nephrology 44:647-51.
3. Arnetz BB, Hörte LG, Hedberg A, Maiker H (1987). Suicide among Swedish dentists. A ten-year follow-up study. Scandinavian Journal of Social Medicine 15:243-246.
4. Arranz LI, Canela MÁ, Rafecas M (2010). Fibromyalgia and nutrition, what do we know? Rheumatology International 30:1417-1427.
5. Ask K, Akesson A, Berglund M, Vahter M (2002). Inorganic mercury and methylmercury in placentas of Swedish women. Environmental Health Perspectives 110:523-526.
6. Agency for Toxic Substances and Disease Registry (1999). Toxicological Profile for Mercury. Public Health Service, US Department of Health and Human Services, http://www.atsdr.cdc. gov/toxprofiles/tp46.pdf. Updated March, 1999. Accessed July, 2014.
7. Barcelos GR, Grotto D, De Marco KC, Valentini J, Lengert AV, De Oliveira AA, Garcia SC, Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T (2004). Health effects of dental amalgam exposure: a retrospective cohort study. International Journal of Epidemiology. 33:894-902.
8. Braga GU, Schläwicke Engström K, Cólusl M, Broberg K, Barbosa F Jr (2013). Polymorphisms in glutathione-related genes modify mercury concentrations and antioxidant status in subjects environmentally exposed to methylmercury. The Science of the Total Environment 463-464:319-325.
9. Barregard L, Fabricius-Lagging E, Lundh T, Molne J, Wallin M, Olausson M et al. (2010). Cadmium, mercury, and lead in kidney cortex of living kidney donors: Impact of different exposure sources. Environmental Research 110:47-54.
10. Berlin M, Zalups RK, Fowler BA (2007). Mercury. In: Nordberg G, Fowler RA, Nordberg M, Friberg LT, editors. Handbook on the toxicology of metals. 3. Burlington: Academic Press.
11. Bjorklund G (1989). The history of dental amalgam (in Norwegian). Journal of the Norwegian Medical Association 109:3582-3585.
12. Bjorklund G (1991). Mercury in the dental office. Risk evaluation of the occupational environment in dental care (in Norwegian). Journal of the Norwegian Medical Association 111:948-951.
13. Bjørklund G (2013). The role of zinc and copper in autism spectrum disorders. Acta Neurobiologiae Expermentalis 73:225-236.
14. Björkman L, Lundekvam BF, Laegreid T, Bertelsen BL, Morild I, Lilleng P et al. (2007). Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environmental Health 6:30.
15. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al. (2010). Prevalence of fibromyalgia: a survey in five European countries. Seminars in Arthritis and Rheumatism 39:448-453.
16. Branco V, Canário J, Lu J, Holmgren A, Carvalho C (2012a). Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. Free Radical Biology & Medicine 52:781-793.
17. Branco V, Ramos P, Canário J, Lu J, Holmgren A, Carvalho C (2012b). Biomarkers of adverse response to mercury: histopathology versus thioredoxin reductase activity. Journal of Biomedicine & Biotechnology 2012:359879.
18. Brune D (1985). A model for recording mercury release from an amalgam surface. Biomaterials 6:357-359.
19. Brune D (1986). Metal release from dental biomaterials. Biomaterials 7:163-175.
20. Brune D (1988). Mechanisms and kinetics of metal release from dental alloys. International Endodontic Journal 21:135-142.
21. Brune D, Evje DM (1985). Man's mercury loading from a dental amalgam. The Science of the Total Environment 44:51-63.
22. CalEPA (California Environmental Protection Agency) (2008). Mercury. In: Mercury reference exposure levels: technical support document for noncancer RELs, Appendix D. I. F. Office of Environmental Health Hazard Assessment.
23. Chang MY, Tseng CH, Chiou YL (2014). The plasma concentration of copper and prevalence of depression were positively correlated in shift nurses. Biological Research for Nursing 16:175-181.
24. Clarkson TW (1987). Mercury. In: Trace Elements in Human and Animal Nutrition. 5th Ed. Vol. 1 (Mertz W, ed.). New York: Academic Press, p. 417-428.
25. Clarkson TW (1989). Mercury. Journal of the American College of Toxicology 8:1291-1296.
26. Clarkson TW (2002). The three modern faces of mercury. Environmental Health Perspectives 110(Suppl 1):11-23.
27. Clarkson TW, Friberg L, Nordberg GF, Sager P (1988). Biological Monitoring of Metals. New York, NY: Plenum Press.
28. Clarkson TW, Magos L (2006). The toxicology of mercury and its chemical compounds. Critical Reviews in Toxicology 36:609-662.
29. Clauw DJ (1995). The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Medical Hypotheses 44:369-378.
30. Custodio HMI, Harari R, Gerhardsson L, Skerfving S, Broberg K (2005). Genetic influences on the retention of inorganic mercury. Archives of Environmental and Occupational Health 60:17-23.
31. Custodio HMI, Broberg K, Wennberg M, Jansson JH, Vessby B, Hallmans G, Stegmayr B, Skerfving S (2004). Polymorphisms in glutathione-related genes affect methylmercury retention. Archives of Environmental and Occupational Health 59:588-95.
32. Davis GK, Mertz W (1987). Copper. In: Trace Elements in Human and Animal Nutrition. 5th Ed. Vol. 1 (Mertz W, ed.). New York: Academic Press, p. 301-364.
33. Dehaene S, Changeux JP (2011). Experimental and theoretical approaches to conscious processing. Neuron 70:200-227.
34. De Rouen TA, Martin MD, Leroux BG, Townes BD, Woods JS, Leitao J et al. (2006). Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. Journal of the American Medical Association 295:1784-1792.
35. Diaz Heijtz RI, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A et al. (2011). Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences United States of America 108:3047-3052.
36. Dixon SE (1998). Amalgams still viable, safe treatment, controversies notwithstanding. Journal of the Indiana Dental Association 77:37-40.
37. Drasch G, Schupp I, Hofl H, Reinke R, Roider G (1994). Mercury burden of human fetal and infant tissues. European Journal of Pediatrics 153:607-610.
38. Drasch G, Aigner S, Roider G, Staiger F, Lipowsky G (1998). Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors. Journal of Trace Elements in Medicine and Biology 12:23-27.
39. Dunn JE, Trachtenberg FL, Barregard L, Bellinger D, McKinlay S (2008). Scalp hair and urine mercury content of children in the Northeast United States: the New England Children's Amalgam Trial. Environmental Research 107:79-88.
40. Duplinsky TG, Cicchetti DV (2012). The health status of dentists exposed to mercury from silver amalgam tooth restorations. International Journal of Statistics in Medical Research 1:1-15.
41. Echeverria D, Aposhian HV, Woods JS, Heyer NJ, Aposhian MM, Bittner AC Jr et al. (1998). Neurobehavioral effects from exposure to dental amalgam Hg (0): new distinctions between recent exposure and Hg body burden. Federation of American Societies for Experimental Biology Journal 12:971-980.
42. Echeverria D, Heyer NJ, Martin MD, Naleway CA, Woods JS, Bittner AC Jr (1995). Behavioral effects of low-level exposure to elemental Hg among dentists. Neurotoxicology and Teratology 17:161-168.
43. Echeverria D, Woods JS, Heyer NJ, Rohlman DS, Farin FM, Bittner AC Jr et al. (2005). Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicology and Teratology 27:781-796.
44. Echeverria D, Woods JS, Heyer NJ, Martin MD, Rohlman DS, Farin FM et al. (2010). The association between serotonin transporter gene promotor polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. Journal of Toxicology and Environmental Health Part A 73:1003-1020.
45. Echeverria D, Woods JS, Heyer NJ, Rohlman D, Farin FM, Li T et al. (2006). The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicology and Teratology 28:39-48.
46. Ekstrand JI, Nielsen JB, Havarinasab S, Zalups RK, Soderkvist P, Hultman P (2010). Mercury toxicokinetics-dependency on strain and gender. Toxicology and Applied Pharmacology 243:283-291.
47. Eneström S, Hultman P (1995). Does amalgam affect the immune system? A controversial issue. International Archives of Allergy Immunology 106:180-203.
48. EPA (US Environmental Protection Agency) (1995). Mercury, elemental: reference concentration for chronic inhalation exposure (RfC). In: Integrated risk information system. US Environmental Protection Agency, http://www.epa.gov/iris/subst/0370.htm. Accessed December, 2014.
49. Eto K (2006). Minamata disease: a neuropathological viewpoint (in Japanese). Seishin Shinkeigaku Zasshi 108:10-23.
50. Faria Mde A (2003). Chronic occupational metallic mercurialism (in Portuguese). Revista de saude publica 37:116-127.
51. Farina M, Avila DS, Da Rocha JB, Aschner M (2013). Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochemistry International 62:575-594.
52. Fauci AS (2008). Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical.
53. Ferracane JL (2001). Materials in dentistry: principles and applications. Philadelphia, PA: Lippincott Williams & Wilkins.
54. Friberg L, Kullman L, Lind B, Nylander M (1986). Mercury in the central nervous system in relation to amalgam fillings (in Swedish). Lakartidningen 83:519-522.
55. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine 121:953-959.
56. Geier DA, Carmody T, Kern JK, King PG, Geier MR (2011). A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children's dental amalgam trial. Biometals 24:215-224.
57. Geier DA, Carmody T, Kern JK, King PG, Geier MR (2012). A dose-dependent relationship between mercury exposure from dental amalgams and urinary mercury levels: a further assessment of the Casa Pia Children's Dental Amalgam Trial. Human and Experimental Toxicology 31:11-17.
58. Geier DA, Carmody T, Kern JK, King PG, Geier MR (2013). A significant dose-dependent relationship between mercury exposure from dental amalgams and kidney integrity biomarkers: a further assessment of the Casa Pia children's dental amalgam trial. Human and Experimental Toxicology 32:434-440.
59. Gerstner HB, Huff JE (1977). Clinical toxicology of mercury. Journal of Toxicology and Environmental Health 2:491-526.
60. Gilmour CC, Podar M, Bullock AL, Graham AM, Brown SD, Somenahally AC et al. (2013). Mercury methylation by novel microorganisms from new environments. Environmental Science and Technology 47:11810-11820.
61. Goldberg RL, Kaplan SR, Fuller GC (1983). Effect of heavy metals on human rheumatoid synovial cell proliferation and collagen synthesis. Biochemistry and Pharmacology 32:2763-2766.
62. Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P et al. (1995). Sodium 2, 3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. Journal of Pharmacology and Experimental Therapeutics 272:264-274.
63. Gronek I, Kolomaznik M (1989). Serum zinc levels in various mental disorders (in Russian). Zhurnal nevropatologii i psikhiatrii imeni S. S. Korsakova/Ministerstvo zdravookhraneniia Soiuza SSR. 89:126-127.
64. Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A et al. (2006). Dental amalgam and mercury levels in autopsy tissues: food for thought. American Journal of Forensic and Medical Pathology 27:42-45.
65. Hambidge KM, Casey CE, Krebs NF (1986). Zinc, in: Trace Elements in Human and Animal Nutrition. 5th ed. Vol. 2 (Mertz W, ed.). New York: Academic Press, pp. 1-37.
66. Hansen CHI, Nielsen DS, Kverka M, Zakostelska Z, Klimesova K, Hudcovic T et al. (2012). Patterns of early gut colonization shape future immune responses of the host. PLoS One 7:e34043.
67. Heintze SDI, Rousson V (2012). Clinical effectiveness of direct class II restorations - a meta-analysis. Journal of Adhesive Dentistry 14:407-431.
68. Heyer NJ, Echeverria D, Martin MD, Farin FM, Woods JS (2009). Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure, and self-reported symptoms and mood. Journal of Toxicology and Environmental Health Part A 72:599-609.
69. Hilt B, Svendsen K, Syversen T, Aas O, Qvenild T, Sletvold H et al. (2009). Occurrence of cognitive symptoms in dental assistants with previous occupational exposure to metallic mercury. Neurotoxicology 30:1202-1206.
70. Holmes AS, Blaxill MF, Haley BE (2003). Reduced levels of mercury in first baby haircuts of autistic children. International Journal of Toxicology 22:277-285.
71. Homme KG, Kern JK, Haley BE, Geier DA, King PG, Sykes LK et al. (2014). New science challenges old notion that mercury dental amalgam is safe. Biometals 27:19-24.
72. Hybenova M, Hrda P, Prochazkova J, Stejskal V, Sterzl I (2010). The role of environmental factors in autoimmune thyroiditis. Neuro Endocrinology Letters 31:283-289.
73. Ida-Eto M, Oyabu A, Ohkawara T, Tashiro Y, Narita N, Narita M (2013). Prenatal exposure to organomercury, thimerosal, persistently impairs the serotonergic and dopaminergic systems in the rat brain: implications for association with developmental disorders. Brain and Development 35:261-264.
74. Ida-Eto M, Oyabu A, Ohkawara T, Tashiro Y, Narita N, Narita M (2011). Embryonic exposure to thimerosal, an organomercury compound, causes abnormal early development of serotonergic neurons. Neuropharmacology 60:1347-1354.
75. International Programme on Chemical Safety (1991). Environmental Health Criteria 118: Inorganic mercury. WHO, Geneva. http://www.inchem.org/documents/ehc/ehc/ehd 18.htm. Accessed July, 2014.
76. Islam MR, Ahmed MU, Mitu SA, Islam MS, Rahman GK et al. (2013). Comparative analysis of serum zinc, copper, manganese, iron, calcium, and magnesium level and complexity of interelement relations in generalized anxiety disorder patients. Biological and Trace Element Research 154:21-27.
77. Kade IJ (2012). Mercury toxicity on sodium pump and organoseleniums intervention: a paradox. Journal of Biomedicine & Biotechnology 924549.
78. Kakita A, Wakabayashi K, Su M, Sakamoto M, Ikuta F, Takahashi H (2000). Distinct pattern of neuronal degeneration in the fetal rat brain induced by consecutive transplacental administration of methylmercury. Brain Research 859:233-239.
79. Kern JK, Geier DA, Audhya T, King PG, Sykes L, Geier M (2012). Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiologiae Expermentalis (Warsz) 72:113-153.
80. Kobal AB, Horvat M, Prezelj M, Briski AS, Krsnik M, Dizdarevic T et al. (2004) The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. Journal of Trace Elements in Medicine and Biology 17:261-274.
81. Kobal Grum D, Kobal AB, Arneric N, Horvat M, Zenko B, Dzeroski S et al. (2006). Personality traits in miners with past occupational elemental mercury exposure. Environmental Health Perspectives 114:290-296.
82. Kokayi K, Altman CH, Callely RW, Harrison A (2006). Findings of and treatment for high levels of mercury and lead toxicity in ground zero rescue and recovery workers and lower Manhattan residents. Explore (NY) 2:400-407.
83. Kostial K (1986). Cadmium. In: Trace Elements in Human and Animal Nutrition. 5th edition. Vol. 2 (Mertz W, ed.). Academic Press, San Diego, p. 319-345.
84. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58:26-35.
85. Limon-Pacheco JHI, Gonsebatt ME (2010). The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Central Nervous System Agents in Medicinal Chemistry 10:287-297.
86. Lindh U, Hudecek R, Danersund A, Eriksson S, Lindvall A (2002). Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuro Endocrinology Letters 23:459-482.
87. Li WX, Chen SF, Chen LP, Yang GY, Li JT, Liu HZ, Zhu W (2012). Thimerosal-induced apoptosis in mouse C2C12 myoblast cells occurs through suppression of the PI3K/Akt/survivin pathway. PLoS One 7:e49064.
88. Lorscheider FL, Vimy MJ, Summers AO (1995a). Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm. Federation of American Societies for Experimental Biology Journal 9:504-508.
89. Lorscheider FLI, Vimy MJ, Summers AO, Zwiers H (1995b). The dental amalgam mercury controversy-inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria. Toxicology 97:19-22.
90. Lubran MM (1980). Lead toxicity and heme biosynthesis. Ann Clin Lab Sci 10:402-413.
91. Luglie PF, Campus G, Chessa G, Spano G, Capobianco G, Fadda GM, Dessole S (2005). Effect of amalgam fillings on the mercury concentration in human amniotic fluid. Archives of Gynecology and Obstetrics 271:138-142.
92. Maes M, Leunis JC (2008). Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from Gram-negative bacteria. Neuro Endocrinology Letters 29:902-910.
93. Maes M, Mihaylova I, De Ruyter M (2006). Lower serum zinc in chronic fatigue syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. Journal of Affective Disorders 90:141-147.
94. Makhija SK, Gordan W, Gilbert GH, Litaker MS, Rindal DB, Pihlstrom DJ et al. (2011) Practitioner, patient and carious lesion characteristics associated with type of restorative material: findings from The Dental Practice-Based Research Network. Journal of the American Dental Association 142:622-632.
95. Marcusson JA, Lindh G, Evengard B (1999). Chronic fatigue syndrome and nickel allergy. Contact Dermatitis 40:269-272.
96. Martin MD, Naleway C, Chou HN (1995). Factors contributing to mercury exposure in dentists. Journal of the American Dental Association 126:1502-1511.
97. McComb D (1997). Occupational exposure to mercury in dentistry and dentist mortality. Journal of the Canadian Dental Association 63:372-376.
98. Miller DM, Woods JS (1993). Redox activities of mercury-thiol complexes: implications for mercury-induced porphyria and toxicity. Chemico-Biological Interactions 88:23-35.
99. Ministry of the Environment (2007). Bans mercury in products. Press release, 21.12.2007. https://www.regjeringen. no/en/aktuelt/Bans-mercury-in-products/id495138. Accessed December, 2014.
100. Moen B, Hollund B, Riise T (2008). Neurological symptoms among dental assistants: a cross-sectional study. Journal of Occupational and Medical Toxicology 3:10.
101. Mortazavi SM, Neghab M, Anoosheh SM, Bahaeddini N, Mortazavi G, Neghab P et al. (2014). High-field MRI and mercury release from dental amalgam fillings. International Journal of Occupational and Environmental Medicine 5:101-105.
102. Mortazavi SM, Daiee E, Yazdi A, Khiabani K, Kavousi A, Vazirinejad R et al. (2008). Mercury release from dental amalgam restorations after magnetic resonance imaging and following mobile phone use. Pakistan Journal of Biological Sciences 11:1142-1146.
103. Mutter J, Naumann J, Guethin C (2007). Comments on the article, 'the toxicology of mercury and its chemical compounds' by Clarkson and Magos (2006) Critical Reviews in Toxicology 37:537-549.
104. Mutter J, Naumann J, Sadaghian C, Walach H, Drasch G (2004). Amalgam studies: disregarding basic principles of mercury toxicity. International Journal of Hygiene and Environmental Health 207:391-397.
105. Narang RL, Gupta KR, Narang AP, Singh R (1991). Levels of copper and zinc in depression. Indian Journal of Physiology and Pharmacology 35:272-274.
106. Ngim CH, Foo SC, Boey KW, Jeyaratnam J (1992). Chronic neurobehavioural effects of elemental mercury in dentists. British Journal of Industrial Medicine 49:782-790.
107. Nyland JF, Fairweather D, Shirley DL, Davis SE, Rose NR, Silbergeld EK (2012). Low-dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice. Toxicological Sciences 125:134-143.
108. Olstad ML, Holland Rl, Wandel N, Pettersen AH (1987). Correlation between amalgam restorations and mercury concentrations in urine. Journal of Dental Research 66:1179-1182.
109. Oskarsson A, Schiiltz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ (1996). Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Archives of Environmental Health 51:234-241.
110. Oteiza PI, Mackenzie GG (2005). Zinc, oxidant-triggered cell signaling, and human health. Molecular Aspects in Medicine 26:245-255.
111. Palkovicova L, Ursinyova M, Masanova V, Yu Z, Hertz-Picciotto I (2008). Maternal amalgam dental fillings as the source of mercury exposure in developing fetus and newborn. Journal of Exposure Science and Environmental Epidemiology 18:326-331.
112. Pergola G, Ranft A, Mathias K, Suchan B (2013). The role of the thalamic nuclei in recognition memory accompanied by recall during encoding and retrieval: An fMRI study. Neuroimage 74:195-208.
113. Pieczenik SR, Neustadt J (2007). Mitochondrial dysfunction and molecular pathways of disease. Experimental and Molecular Pathology 83(1):84-92.
114. Prasad AS (1995). Zinc: an overview. Nutrition 11(1 Suppl):93-99.
115. Prasad AS (2012). Discovery of human zinc deficiency: 50 years later. Journal of Trace Elements and Medical Biology 26:66-69.
116. Prasad AS, Beck FW, Grabowski SM, Kaplan J, Mathog RH (1997). Zinc deficiency: changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects. Proceedings of the Association of American Physicians 109:68-77.
117. Prins JB, Van Der Meer JW, Bleijenberg G (2006). Chronic fatigue syndrome. Lancet 367:346-355.
118. Prochazkova JI, Sterzl I, Kucerova H, Bartova J, Stejskal VD (2004). The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuro Endocrinology Letters 25:211-218.
119. Regland B, Zachrisson O, Stejskal V, Gottfries C (2001). Nickel allergy is found in a majority of women with chronic fatigue syndrome and muscle pain. Journal of Chronic Fatigue Syndrome 8:57-65.
120. Richardson GM, Wilson R, Allard D, Purtill C, Douma S, Graviere J (2011). Mercury exposure and risks from dental amalgam in the US population, post-2000. The Science of the Total Environment 409:4257-4268.
121. Russo AJ (2011). Analysis of plasma zinc and copper concentration, and perceived symptoms, in individuals with depression, post zinc and anti-oxidant therapy. Nutrition and Metabolic Insights 4:19-27.
122. Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W (2009). Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clinical and Experimental Rheumatology 27 (5 Suppl 56):S67-S74.
123. Shapiro IM, Cornblath DR, Sumner AJ, Uzzell B, Spitz LK, Ship II et al. (1982). Neurophysiological and neuropsychological function in mercury-exposed dentists. Lancet 1:1147-1150.
124. Sharpe M, Campling F (2008). Chronic fatigue syndrome (CFS/ME). New York, NY: Oxford University Press.
125. Shin SR, Han AL (2012). Improved chronic fatigue symptoms after removal of mercury in patient with increased mercury concentration in hair toxic mineral assay: a case. Korean Journal of Family Medicine 33:320-325.
126. Sen CK. 1997. Nutrition biochemistry of cellular glutathione. J Nutr Biochem 8:660-672
127. Siblerud RL, Kienholz E (1994). Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. The Science of the Total Environment 142:191-205.
128. Siblerud RL, Motl J, Kienholz E (1994). Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychological Reports 74:67-80.
129. Sirois JE, Atchison WD (1996). Effects of mercurials on ligandand voltage-gated ion channels: a review. Neurotoxicology 17:63-84.
130. Sivri A, Cindas A, Dincer F, Sivri B (1996). Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clinical Rheumatology 15:283-286.
131. Sjursen TT, Lygre GB, Dalen K, Helland V, Laegreid T, Svahn J et al. (2011). Changes in health complaints after removal of amalgam fillings. Journal of Oral Rehabilitation 38:835-848.
132. Sowa-Kucma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W et al. (2013). Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. Journal of Affective Disorders 151:924-931.
133. Stejskal VD, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A et al. (1999). Metal-specific lymphocytes: biomarkers of sensitivity in man. Neuro Endocrinology Letters 20:289-298.
134. Stejskal V, Hudecek R, Stejskal J, Sterzl I (2006). Diagnosis and treatment of metal-induced side-effects. Neuro Endocrinology Letters 27(Suppl 1):7-16.
135. Stejskal V, Ockert K, Bjorklund G (2013). Metal-induced inflammation triggers fibromyalgia in metal-allergic patients. Neuro Endocrinology Letters 34:559-565.
136. Stenman S, Grans L (1997). Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings. Scandinavian Journal of Work and Environmental Health 23 Suppl 3:59-63.
137. Sterzl I, Prochazkova J, Hrda P, Bartova J, Matucha P, Stejskal VD (1999). Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuro Endocrinology Letters 20:221-228.
138. Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB et al. (1993). Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal flora of primates. Antimicrobial Agents and Chemotherapy 37:825-834.
139. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctot KL (2013a). Zinc in depression: a meta-analysis. Biological Psychiatry 74:872-878.
140. Swardfager W, Herrmann N, Mclntyre RS, Mazereeuw G, Goldberger K, Cha DS et al. (2013b). Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience and Biobehavioral Reviews 37:911-929.
141. Swedish Chemicals Agency (2008-2012). The Swedish Chemicals Agency's Chemical products and biotechnical organisms regulations. KIFS 2008:2 in English, consolidated up to KIFS 2012:3.
142. Takahashi Y, Tsuruta S, Hasegawa J, Kameyama Y, Yoshida M (2001). Release of mercury from dental amalgam fillings in pregnant rats and distribution of mercury in maternal and fetal tissues. Toxicology 163:115-126.
143. Takahashi Y, Tsuruta S, Arimoto M, Tanaka H, Yoshida M (2003). Placental transfer of mercury in pregnant rats which received dental amalgam restorations. Toxicology 185:23-33.
144. Tao L, Zheng Y, Shen Z, Li Y, Tian X, Dou X, Qian J, Shen H (2013). Psychological stress-induced lower serum zinc and zinc redistribution in rats. Biol Trace Elem Res 155:65-71.
145. Taut C (2014). Dental amalgam: is this the end? Journal of the Irish Dental Association 59(6):311-7.
146. Tchounwou PB, Ayensu WK, Ninashvili N, Sutton D (2003). Environmental exposure to mercury and its toxicopathologic implications for public health. Environmental Toxicology 18:49-75.
147. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, et al. (2004). Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 93:97-108.
148. Underwood E (1977). Trace Elements in Human Health and Disease. 4th ed. New York, NY: Academic Press.
149. US Public Health Service (1997). Dental amalgam and alternative restorative materials: An update report to the Environmental Health Policy Committee. Washington, DC: US Department of Health and Human Services.
150. Uzzell BP, Oler J (1986). Chronic low-level mercury exposure and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology 8:581-593.
151. Vahter M, Akesson A, Lind B, Bjors U, Schutz A, Berglund M (2000). Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environmental Research 84:186-194.
152. Vas J, Monesteir M (2008). Immunology of mercury. Annals of the New York Academy of Sciences 1143:240-267.
153. Vimy MJ, Lorscheider FL (1985). Serial measurements of intraoral air mercury: estimation of daily dose from dental amalgam. Journal of Dental Research 64:1072-1075.
154. Werbach MR (2000). Nutritional strategies for treating chronic fatigue syndrome. Alternative Medicine Reviews 5:93-108.
155. Wojcik DP, Godfrey ME, Christie D, Haley BE (2006). Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006). Neuro Endocrinology Letters 27:415-423.
156. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33:160-172.
157. Wolfe F, Brahler E, Hinz A, Hauser W (2013). Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care and Research (Hoboken) 65:777-785.
158. Woods JS (1996). Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity. Canadian Journal of Physiology and Pharmacology 74:210-215.
159. Woods JS, Martin MD, Leroux BG, De Rouen TA, Leitao JG, Bernardo MF, et al. (2007). The contribution of dental amalgam to urinary mercury excretion in children. Environmental Health Perspectives 115:1527-1531.
160. Woods JS, Heyer NJ, Echeverria D, Russo JE, Martin MD, Bernardo MF et al. (2012). Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children. Neurotoxicology and Teratology 34:513-521.
161. Woods JS, Heyer NJ, Russo JE, Martin MD, Pillai PB, Bammler TK et al. (2014). Genetic polymorphisms of catechol-O-methyltransferase modify the neurobehavioral effects of mercury in children. Journal of Toxicology and Environmental Health Part A 77:293-312.
162. Woods JS, Heyer NJ, Russo JE, Martin MD, Pillai PB, Farin FM (2013). Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children. Neurotoxicology and Teratology 39:36-44.
163. World Health Organization: Mercury in Health Care, http://www.who.int/water-sanitation-health/medicalwaste/mercurypolpaper.pdf. Updated August, 2005. Accessed December, 2014.
164. Yaqob A, Danersund A, Stejskal VD, Lindvall A, Hudecek R, Lindh U (2006). Metal-specific lymphocyte reactivity is downregulated after dental metal replacement. Neuro Endocrinology Letters 27:189-197.
165. Zachi EC, DFV, Faria MA, Taub A (2007). Neuropsychological dysfunction related to earlier occupational exposure to mercury vapor. Brazilian Journal of Medical and Biological Research 40:425-433.
166. Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, Murck H (2013). New paradigms for treatment-resistant depression. Annals of the New York Academy of Sciences 1292:21-31.
167. Zhou T, Rademacher DJ, Steinpreis RE, Weis JS (1999). Neurotransmitter levels in two populations of larval Fundulus heteroclitus after methylmercury exposure. Comparative Biochemistry and Physiology Part C, Pharmacology, Toxicology, & Endocrinology 124:287-294.